or browse our products catalogue
Anti-human CD4 FITC conjugated 0.5ml
Biological activities of Rituximab WHO 1st International Standard
WHO International Standard 1st International Standard for Infliximab
Adalimumab (1st WHO International Standard)
Bevacizumab (1st WHO International Standard)
Trastuzumab (1st WHO international Standard)
1st International Standard 2022 for the in vitro bioactivities of Cetuximab
Golimumab